Gene Company Pty Ltd vs. The Trustees of Columbia University in the City of New York et al.

Explore the PTAB proceeding IPR2024-00312 filed by Gene Company Pty Ltd on 2023-12-19. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2024-00312

Filing Date

2023-12-19

Accorded Filing Date

2023-12-19

Institution Decision Date

2024-06-24

Last Modified Date

2025-04-07

Proceeding Type

IPR

Termination Date

2025-01-28

Trial Status

Terminated-Adverse Judgment

Parties & Counsel

Petitioner

Gene Company Pty Ltd

Represented By

Mills, Jadet al

Patent Owner / Respondent

The Trustees of Columbia University in the City of New York et al.

Represented By

Feldstein, Market al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 14510975

Respondent Patent Number 9486432

External Links

Espacenet

Google Patents

Respondent Inventor Ilyas Washington

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

71 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name MCCARTER & ENGLISH, LLP BOSTON

Customer Number 86738

Address 265 Franklin Street, Boston, MA, 02110, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
27026	David Conlin	617-348-1856
31645	Basam Nabulsi	203-399-5920
32470	Thomas Hoover	617-449-6500
32555	James Bollinger	212-704-6000
32615	Mark Giarratana	860-275-6700
33715	John Isacson Jr	202-753-3400
33884	Michael Friscia	973-848-8308
38162	Michael Gnibus	203-895-0606
38364	Catherine Winter	314-342-7807
39652	Steven Davis	617-449-6580
40955	Dave Christensen	860-275-6709
41129	Basil Krikelis	302-984-6393
41289	Michael Sartori	202-344-4004
41658	Kathleen Carr	617-348-1857
43040	Kevin Reiner	860-275-6756
46590	David Burns	617-449-6500
46741	Eric Grondahl	860-275-6704
47577	Kia Freeman	617-449-6549
48319	Mark Nikolsky	973-639-6987
50306	Yu Lu	617-449-6500
50445	John Curran	617-449-6500
50749	Leigh Martinson	617-449-6500
51993	Jeffrey Mann	212-609-6811
53624	Jonathan Sparks	617-449-6500
54689	Jeffrey Safran	302-984-6357
55098	Dennis Darcy	617-449-6518
55144	Kathleen Ehrhard	212-588-0800
55450	Jill Mello	617-449-6500
56266	Maria Laccotripe Zacharakis	617-449-6500
58063	Matthew Van Eman	617-449-6500
59978	Deborah Nagle	617-449-6500
60821	Jonathan Lovely	617-443-9292
60963	Maneesh Gulati	617-994-0773
61189	Anita Bowles	617-449-6528
62139	Xin Zhang	617-449-6500
62397	Sean Varley	720-200-0676
63723	Marcie Clarke	617-449-6500
64320	Wei Song	860-961-7158
64760	Joseph Ciardi	215-979-3834
65243	Vadim Cherkasov	215-979-3893
66083	James Smedley	732-564-5443
66174	Timothy Homlish	973-379-7252
68901	Michael Degrazia	617-449-6585
71771	Zhongyu Wang	631-220-4231
72864	Oliver Han	857-758-5747
73368	Adam Kehres	864-271-1592
73381	George Blazeski	617-449-6500
73842	Alex Korona	973-849-4040
74908	Joshua Friedman	212-609-6887
76156	Nicholas Caiafa	212-209-4365
76164	Sujatha Rochford	617-449-6517
77041	Alexa Marie Derkasch	973-639-7992
77293	James Alburger	860-275-6785
78384	Andrew Ehle	857-300-4074
79164	Wei Zhang	202-741-8206
79354	Miao Yu	857-998-1341
79367	Jacob Alexander	203-536-9906
79497	Daniel Jones	413-949-3087
79656	Benjamin Ailes	215-988-3095
79687	Dylan Blumenthal	617-449-6500
800057	Sanandan Malhotra	574-387-1109
800082	Nandini Mani	617-449-6500
80174	Lingling Zhao	518-867-2837
80508	Yanjun Feng	281-231-3168
80974	Baiwei Sun	202-741-8217
81302	Yelena Margolin	617-449-6587
81488	Katarina Overberg	617-449-6614
82336	Fangyan Zhang	212-609-6908
82368	Mohamed Khames Ben Hadj Miled	617-849-3410
82428	Dale Park	212-321-0351
L1397	Thao Nguyen	617-449-6583

Proceeding Documents

Adverse judgment: post-institution ADVRSJUDG

2025-01-28 FILING PARTY: BOARD

Download

3001

Ex. 3001 Exhibit

2024-09-30 FILING PARTY: BOARD

Download

Notice of Stipulation to Modify Trial Due Dates 1-3 NOTICE

2024-09-05 FILING PARTY: PATENT OWNER

Download

Patent Owner's Notice of Deposition of Dr. F. Peter Guengerich NOTICE

2024-07-29 FILING PARTY: PATENT OWNER

Download

Patent Owner's Notice of Deposition of Dr. Andrew Calman NOTICE

2024-07-29 FILING PARTY: PATENT OWNER

Download

Gene Company Pty Ltd vs. The Trustees of Columbia University in the City of New York et al.

Proceeding Overview

Parties & Counsel

Petitioner

Gene Company Pty Ltd

Represented By

Patent Owner / Respondent

The Trustees of Columbia University in the City of New York et al.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Adverse judgment: post-institution ADVRSJUDG

Ex. 3001 Exhibit

Notice of Stipulation to Modify Trial Due Dates 1-3 NOTICE

Patent Owner's Notice of Deposition of Dr. F. Peter Guengerich NOTICE

Patent Owner's Notice of Deposition of Dr. Andrew Calman NOTICE

Patent Owner's Objections to Evidence OTHER

Decision Granting Institution of Inter Partes Review DECISION

Scheduling Order ORDER

Patent Owner's Updated Mandatory Notices NOTICE

PO's Updated Mandatory Notices NOTICE

PO's Updated Power of Attorney NOTICE

Notice : Mandatory Notice NOTICE

Notice : Power of Attorney NOTICE

Petitioner's Updated Mandatory Notices NOTICE

Notice: Notice filing date accorded NOTICE

Kemp, C. Visual Function and Rhodopsin Levels in Humans with Vitamin A Defi Exhibit

Furr, H. C., Amedee-Manesme, O., Clifford, A. J., Bergen 3rd, H. R., Jones, Exhibit

Sparrow JR, Fishkin N, Zhou J, Cai B, Jang YP, Krane S, Itagaki Y, Nakanish Exhibit

Rosenfeld, P.J. et al. Ranibizumab for Neovascular Age-Related Macular Dege Exhibit

Alberts D et al., Safety and Efficacy of Dose-intensive Oral Vitamin A in S Exhibit

Switching’ in Cytochrome P450‐catalyzed Reactions, BioEssays, 7(5), 215-219 Exhibit

Shaban et al., Phosphatidylglycerol Potently Protects Human Retinal Pigment Exhibit

Baillie, T. A., The Use of Stable Isotopes in Pharmacological Research, Pha Exhibit

Petitioner Gene Company Pty Ltd Power of Attorney NOTICE

J. A. Olson, The Biosynthesis and Metabolism of Carotenoids and Retinol (Vi Exhibit

U.S. Patent No. 9,486,432 to Washington et al. Exhibit

Wolf, G., A History of Vitamin A and Retinoids. The FASEB Journal, 10: 1102 Exhibit

Duszka, et al., Rat Intestinal β-Carotene Dioxygenase Activity Is Located P Exhibit

Jacobson SG, Cideciyan AV, Regunath G, Rodriguez FJ, Vandenburgh K, Sheffie Exhibit

WO 95/04018 to Marcus F. Boehm (“Boehm”) Exhibit

Petition : as filed PETITION

Shaban & Richter, A2E and Blue Light in the Retina: The Paradigm of Age-rel Exhibit

Curriculum Vitae of Dr. Guengerich. Exhibit

Age-Related Eye Disease Study Research Group, A Randomized, Placebo-control Exhibit

Curriculum Vitae of Dr. Calman. Exhibit

Haskins, N. J., The Application of Stable Isotopes in Biomedical Research, Exhibit

File History of U.S. Patent Application No. 12/733,631 Exhibit

McCullough FS, Northrop-Clewes CA, Thurnham DI. The Effect of Vitamin A on Exhibit

Del Priore LV, Kuo YH, Tezel TH. Age-related Changes in Human RPE Cell Dens Exhibit

Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C Exhibit

Haskell MJ, et al., Assessment of Vitamin A Status by the Deuterated-retino Exhibit

McCarty LP, Malek RS, Larsen ER. The Effects of Deuteration on the Metaboli Exhibit

Declaration of Dr. F. Peter Guengerich, Ph.D. Exhibit

Radu, Roxana A. et al. “Treatment with Isotretinoin Inhibits Lipofuscin Acc Exhibit

File History of U.s. Patent Application No. 14/510,975 Exhibit

Blake MI, Crespi HL, Katz JJ, Studies with Deuterated Drugs, J Pharm Sci. 6 Exhibit

Van Langenhove, A., Isotope Effects: Definitions and Consequences for Pharm Exhibit

Roth and König, Kinetic Isotope Effect of the 1.5-Hydrogen Displacement in Exhibit

Bull E. What is Nutraceutical? Pharm J. 265:57-58 (2000) (“Bull”) Exhibit

Ross DA, Recommendations for Vitamin A Supplementation. J Nutr. 132(9 Suppl Exhibit

Chopdar A, Chakravarthy U, Verma D, Age Related Macular Degeneration. BMJ ( Exhibit

First Declaration of Irinia Hinrichs Exhibit

Sommer, A. Oral Versus Intramuscular Vitamin A in the Treatment of Xerophth Exhibit

Fishkin N, Jang YP, Itagaki Y, Sparrow JR, Nakanishi K. A2-Rhodopsin: A New Exhibit

Kushner DJ, Baker A, Dunstall TG, Pharmacological Uses and Perspectives of Exhibit

Haskell MJ et al., Use of the Deuterated-retinol-dilution Technique to Asse Exhibit

Sieving PA, Chaudhry P, Kondo M, Provenzano M, Wu D, Carlson TJ, Bush RA, T Exhibit

Mata, N. L. et al., Biosynthesis of a major lipofuscin fluorophore in mice Exhibit

Radu, Roxana A. et al., Reductions in Serum Vitamin A Arrest Accumulation o Exhibit

Remington: The Science and Practice of Pharmacy, 19th ed. (1995) (chs. 80 & Exhibit

Parish et al., Isolation and One-step Preparation of A2E and Iso-A2E, Gluor Exhibit

Wolf G., Lipofuscin and Macular Degeneration., Nutr Rev. 61(10):342-6 (2003 Exhibit

Ribaya-Mercado et al., “Dietary vitamin A intakes of Filipino elders with a Exhibit

Law WC & Rando RR, The Molecular Basis of Retinoic Acid Induced Night Blind Exhibit

Itou et al., Quantum Treatment of Hydrogen Nuclei in Primary Kinetic Isotop Exhibit